Tumor Biology

, Volume 37, Issue 5, pp 6419–6428 | Cite as

H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma

Original Article
  • 212 Downloads

Abstract

H2.0-like homeobox 1 (HLX1) is a homeobox transcription factor gene expressed primarily in cytotrophoblast cell types in the early pregnancy human placenta and involved in the development of enteric nervous system. However, the biological function of HLX1 in hepatocellular carcinoma (HCC) remains unclear. In the present study, semiquantitative reverse transcription-polymerase chain reaction (RT-PCR), quantitative real-time RT-PCR, western blot, and immunohistochemical staining were used to examine the expression level of HLX1 in a total of 125 cases of HCC tissues and their matched adjacent nontumorous tissues (ANLTs), and its correlation with clinical features of HCC patients was analyzed. Our findings showed that the expression level of HLX1 was significantly reduced in HCCs compared to ANLTs. Besides, it was also remarkably downregulated in HCC cell lines compared to normal liver cell line. We further found that the HLX1 level was significantly associated with the tumor size (p = 0.016), tumor number (p = 0.004), vascular invasion (p = 0.031), Edmondson-Steiner grade (p = 0.041), tumor-node-metastasis (TNM) stage (p < 0.001), and Barcelona clinic liver cancer (BCLC) stage (p = 0.008). Moreover, HLX1 was an independent risk factor for overall survival (OS, p = 0.020) and disease-free survival (DFS, p = 0.024) of HCC patients. In vitro experiments showed that overexpression of HLX1 markedly suppressed the invasion, migration, proliferation, and colony formation of HCC cells; in contrast, downregulation of HLX1 significantly promoted the invasion, migration, proliferation, and colony formation of HCC cells. In vivo study indicated that overexpression of HLX1 significantly inhibited the tumorigenic capacity of HCC cells in nude mice. Based on these findings, we suggest that HLX1 acts as a tumor suppressor in HCC.

Keywords

Hepatocellular carcinoma H2.0-like homeobox 1 Metastasis Proliferation Prognosis 

Notes

Compliance with ethical standards

Conflicts of interest

None

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the legislation and ethical boards of Second Xiangya Hospital of Central South University and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the Medical Experimental Animal Care Commission of Central South University.

References

  1. 1.
    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29.CrossRefPubMedGoogle Scholar
  2. 2.
    Psyrri A, Arkadopoulos N, Vassilakopoulou M, Smyrniotis V, Dimitriadis G. Pathways and targets in hepatocellular carcinoma. Expert Rev Anticancer Ther. 2012;12:1347–57.CrossRefPubMedGoogle Scholar
  3. 3.
    Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, et al. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology. 2008;47:897–907.CrossRefPubMedGoogle Scholar
  4. 4.
    Zhao ZC, Zheng SS, Wan YL, Jia CK, Xie HY. The molecular mechanism underlying angiogenesis in hepatocellular carcinoma: the imbalance activation of signaling pathways. Hepatobiliary Pancreat Dis Int. 2003;2:529–36.PubMedGoogle Scholar
  5. 5.
    Oishi N, Yamashita T, Kaneko S. Molecular biology of liver cancer stem cells. Liver Cancer. 2014;3:71–84.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Kogure T, Lin WL, Yan IK, Braconi C, Patel T. Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology. 2011;54:1237–48.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Meng X, Franklin DA, Dong J, Zhang Y. MDM2-p53 pathway in hepatocellular carcinoma. Cancer Res. 2014;74:7161–7.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Chen J, Gao J. Advances in the study of molecularly targeted agents to treat hepatocellular carcinoma. Drug Discov Ther. 2014;8:154–64.CrossRefPubMedGoogle Scholar
  9. 9.
    Sidhu K, Kapoor NR, Pandey V, Kumar V. The “macro” world of microRNAs in hepatocellular carcinoma. Front Oncol. 2015;5:68.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Li X, Yang W, Lou L, Chen Y, Wu S, Ding G. microRNA: a promising diagnostic biomarker and therapeutic target for hepatocellular carcinoma. Dig Dis Sci. 2014;59:1099–107.CrossRefPubMedGoogle Scholar
  11. 11.
    Shearn CT, Petersen DR. Understanding the tumor suppressor PTEN in chronic alcoholism and hepatocellular carcinoma. Adv Exp Med Biol. 2015;815:173–84.CrossRefPubMedGoogle Scholar
  12. 12.
    Kennedy MA, Rayner JC, Morris CM. Genomic structure, promoter sequence, and revised translation of human homeobox gene HLX1. Genomics. 1994;22:348–55.CrossRefPubMedGoogle Scholar
  13. 13.
    Bates MD, Dunagan DT, Welch LC, Kaul A, Harvey RP. The Hlx homeobox transcription factor is required early in enteric nervous system development. BMC Dev Biol. 2006;6:33.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Rajaraman G, Murthi P, Quinn L, Brennecke SP, Kalionis B. Homeodomain protein HLX is expressed primarily in cytotrophoblast cell types in the early pregnancy human placenta. Reprod Fertil Dev. 2008;20:357–67.CrossRefPubMedGoogle Scholar
  15. 15.
    Jawad M, Seedhouse CH, Russell N, Plumb M. Polymorphisms in human homeobox HLX1 and DNA repair RAD51 genes increase the risk of therapy-related acute myeloid leukemia. Blood. 2006;108:3916–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Martin N, Raguz S, Dharmalingam G, Gil J. Co-regulation of senescence-associated genes by oncogenic homeobox proteins and polycomb repressive complexes. Cell Cycle. 2013;12:2194–9.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Seo HC, Nilsen F, Fjose A. Three structurally and functionally conserved Hlx genes in zebrafish. Biochim Biophys Acta. 1999;1489:323–35.CrossRefPubMedGoogle Scholar
  18. 18.
    Hjorth JT, Connor RM, Key B. Role of hlx1 in zebrafish brain morphogenesis. Int J Dev Biol. 2002;46:583–96.PubMedGoogle Scholar
  19. 19.
    Herbert SP, Cheung JY, Stainier DY. Determination of endothelial stalk versus tip cell potential during angiogenesis by H2.0-like homeobox-1. Curr Biol. 2012;22:1789–94.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Pandolfi A, Steidl U. HLX in AML: novel prognostic and therapeutic target. Oncotarget. 2012;3:1059–60.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Kawahara M, Pandolfi A, Bartholdy B, Barreyro L, Will B, Roth M, et al. H2.0-like homeobox regulates early hematopoiesis and promotes acute myeloid leukemia. Cancer Cell. 2012;22:194–208.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Martin N, Popov N, Aguilo F, O’Loghlen A, Raguz S, Snijders AP, et al. Interplay between Homeobox proteins and Polycomb repressive complexes in p16INK(4)a regulation. EMBO J. 2013;32:982–95.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Xu Y, Gao J, Su Z, Dai X, Li Y, Liu Y, et al. Downregulation of Hlx closely related to the decreased expressions of T-bet and Runx3 in patients with gastric cancer may be associated with a pathological event leading to the imbalance of Th1/Th2. Clin Dev Immunol. 2012;2012:949821.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Clark AG, Vignjevic DM. Modes of cancer cell invasion and the role of the microenvironment. Curr Opin Cell Biol. 2015;36:13–22.CrossRefPubMedGoogle Scholar
  25. 25.
    Frugtniet B, Jiang WG, Martin TA. Role of the WASP and WAVE family proteins in breast cancer invasion and metastasis. Breast Cancer (Dove Med Press). 2015;7:99–109.PubMedCentralGoogle Scholar
  26. 26.
    Pandolfi A, Stanley RF, Yu Y, Bartholdy B, Pendurti G, Gritsman K, et al. PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome. Blood. 2015;126:1118–27.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Ito K, Yanagida A, Okada K, Yamazaki Y, Nakauchi H, Kamiya A. Mesenchymal progenitor cells in mouse foetal liver regulate differentiation and proliferation of hepatoblasts. Liver Int. 2014;34:1378–90.CrossRefPubMedGoogle Scholar
  28. 28.
    Liu X, Tang Z, Zhang Y, Hu J, Li D, Zang G, et al. Lentivirally overexpressed T-bet regulates T-helper cell lineage commitment in chronic hepatitis B patients. Mol Med Rep. 2012;6:361–6.PubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  1. 1.Department of General Surgery, Second Xiangya HospitalCentral South UniversityChangshaChina
  2. 2.Department of General SurgeryPeace Hospital Changzhi Medical CollegeChangzhiChina
  3. 3.Department of Surgery, Xiangya HospitalCentral South UniversityChangshaChina

Personalised recommendations